Daptomycin forms cation- and size-selective pores in model membranes by Zhang, TianHua et al.
Daptomycin forms cation- and size-selective pores in model membranes
TianHua Zhanga, Jawad K. Muraihb, Ben MacCormickc, and Michael Palmerad
aDepartment of Chemistry, University of Waterloo, Waterloo, Ontario, Canada
bDepartment of Chemistry, University of Al-Muthanna, Samawah, Al-Muthanna, Iraq
cBioMedica Diagnostics, Windsor, Nova Scotia, Canada 
dCorresponding author. Email: mpalmer@uwaterloo.ca
1
The final publication is available at Elsevier via http://doi.org/10.1016/j.bbamem.2014.05.014 © 2014. This manuscript 
version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Abstract
Daptomycin is a lipopeptide antibiotic that is used clinically to treat severe infections 
caused by Gram-positive bacteria. Its bactericidal action involves the calcium-dependent 
binding to  membranes  containing phosphatidylglycerol,  followed by the  formation of 
membrane-associated  oligomers.  Bacterial  cells  exposed  to  daptomycin  undergo 
membrane depolarization,  suggesting the formation of channels or pores in the target 
membranes. We here used a liposome model to detect and characterize the permeability 
properties  of  the  daptomycin  pores.  The  pores  are  selective  for  cations,  with 
permeabilities being highest for Na+, K+, and other alkali metal ions. The permeability is 
approximately twice lower for Mg++, and lower again for the organic cations choline and 
hexamethonium. Anions are excluded, as is the zwitterion cysteine. These observations 
account for the observed depolarization of bacterial cells by daptomycin and suggest that 
under typical in vivo conditions depolarization is mainly due to sodium influx. 
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Introduction
Daptomycin is the first clinically approved lipopeptide antibiotic; it has been available for 
injection  under  the  trade  name  Cubicin® since  2003  [1].  It  is  used  to  treat  severe 
infections  caused  by  Gram-positive  bacteria  such  as  Staphylococcus  aureus and 
Enterococcus  faecalis,  including  strains  that  are  resistant  to  β-lactam antibiotics  and 
vancomycin [2, 3]. Daptomycin consists of a cyclic peptide moiety with 10 amino acids, 
from which the N-terminal three amino acids protrude; the N-terminus carries a decanoyl 
fatty  acyl  side  chain  (Figure  1).  The  antibiotic  is  extraribosomally  synthesized  by 
Streptomyces roseosporus [4, 5] and contains several non-standard amino acids. 
Daptomycin acts at the bacterial membrane. Various molecular targets and action modes 
have been proposed, including the inhibition of peptidoglycan  [6] or lipoteichoic acid 
synthesis  [7]. However,  the only effect consistently reported in studies from different 
laboratories  consists  in  the  depolarization  of  the  bacterial  cell  membrane  [8-11]. 
Concomitantly  with  membrane  depolarization,  bacterial  cells  lose  the  ability  to 
accumulate  amino  acid  substrates,  while  leaving  glucose  uptake  intact,  indicating  a 
selective nature of the membrane permeability defect  [9]. No membrane discontinuities 
have  been observed by electron  microscopy [12],  also supporting the  notion that  the 
functional membrane lesion is discrete and small. 
Based  on  precedent  from  other  membrane-damaging  peptides  and  proteins,  it  was 
proposed  early  on  that  daptomycin  acts  through  the  formation  of  oligomeric 
transmembrane  pores  [10];  however,  experimental  evidence  was  only  obtained  more 
recently. Using various fluorescently labeled, functionally active daptomycin derivatives, 
oligomerization was observed both on model liposomes and on bacterial membranes [13-
15],  and it  was  subsequently shown that  oligomerization  is  required  for  antibacterial 
action  [16].  The  model  liposomes  used  in  those  studies  contained  only 
phosphatidylcholine  (PC),  which  is  largely  inert  to  daptomycin  [13],  and 
phosphatidylglycerol  (PG),  which  was  required  to  induce  binding  at  physiologically 
relevant calcium concentration, as well as to trigger oligomer formation. 
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It is noteworthy that the abundance of phosphatidylglycerol in bacterial cell membranes 
is also a major determinant in the susceptibility of bacteria to daptomycin [17-19]. It was 
therefore of interest to determine whether the PC/PG liposome model also suffices to 
support the formation of the functional daptomycin pore, and if so, to characterize the 
pore's  permeability properties. This  study reports  the corresponding experiments.  The 
results  show  that  daptomycin  forms  discrete  pores  on  liposome  membranes  that  are 
selective for cations of limited size.
Materials and methods
Preparation of indicator-loaded large unilamellar vesicles
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 1,2-Dimyristoyl-sn-glycero-
3-phospho-rac-(1’-glycerol)  (DMPG;  both  from  Avanti  Polar  Lipids,  Alabaster,  AL, 
USA) were used to prepare the vesicles. Equimolar amounts of DMPC and DMPG were 
weighed  into  a  round-bottom flask  and  dissolved  in  chloroform/methanol  (3:1).  The 
solvent mixture was then evaporated with nitrogen to produce a ipid film, which was 
further dried under vacuum for three hours and then dispersed in buffer. The resulting 
lipid suspension was extruded through a 100 nm polycarbonate filter 15 times, using a 
nitrogen-pressurized  extruder  to  produce  indicator-loaded  large  unilamellar  liposomes 
[20]. 
The buffers used for dispersing the lipid film contained either pyranine or dithio-bis-
nitrobenzoic acid (DTNB) as indicators for the permeabilization assays, and they varied 
in pH and salt composition as detailed in Table 1. Following polycarbonate membrane 
extrusion, the liposomes were subjected to  gel filtration on a Bio-Rad P-6DG column 
(Bio-Rad, Richmond, CA, USA) in order to remove unentrapped indicator. The column 
buffers used in the gel filtration step matched those used for lipid film rehydration, except 
for the absence of pyranine or DTNB. 
As  indicated  in  Table  1,  all  loading  buffers  also  contained  250  mM  sucrose.  This 
experimental detail was adopted from a previous study [21] and was found to improve the 
stability of the indicator-loaded liposomes. 
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Fluorescence measurements
With  pyranine-loaded  liposomes,  time-based  emission  scans  were  acquired  on  a  PTI 
QuantaMaster  4  system,  the  sample  holder  of  which  was  thermostatted  at  30  ºC. 
Liposome suspensions were diluted to a final concentration of 250 µM of total lipids into 
reaction  buffer  with  5mM  CaCl2.  Daptomycin  (Cubist),   carbonyl  cyanide  m-
chlorophenyl  hydrazine (CCCP, Sigma),  and valinomycin or gramicidin (Sigma) were 
added  as  indicated  to  final  concentrations  of  1  μM,  5  nM,  0.5  μM,  and  10  nM, 
respectively, in order to initiate the reaction. The fluorescence emission at 510 nm was 
recorded for 5 minutes, with excitation at 460 nm. Triton X-100 was then added to a final 
concentration of 0.1%, followed by one more minute of recording; this was done in order 
to disrupt the liposomes and so establish the fluorescence intensity equivalent to 100% 
test solute permeation. 
With cationic test solutes, the reaction buffer was similar to the corresponding liposome 
hydration buffer (see Table 1), but the concentration of the test solute was increased to 
100 mM, and the pH value from 6.00 to 8.00. With the anionic test  solute (Cl -),  the 
reaction buffer was similar to its hydration buffer, but choline chloride was added to 100 
mM, and the pH value was lowered from 8.00 to 6.00. Using the intrinsic fluorescence of 
the kynurenine residue, we confirmed that daptomycin binds quantitatively to the model 
membranes under these experimental conditions (see Figure S1).
Spectrophotometric measurements
The permeation of thiols into the liposomes was measured through reduction of entrapped 
DTNB, which was measured by its absorption at 412 nm (ε=13,400 M-1cm-1). DTNB-
loaded liposomes were diluted to a final concentration of 250 µM total lipids into the 
corresponding hydration buffer (Table 1) supplemented with 100 mM cysteine and 5 mM 
CaCl2. 1 µM daptomycin was added to initiate the reaction.
Assessment of flow rate of different cations through daptomycin pores 
To convert observed changes of pyranine fluorescence to permeation rates of cations, a 
calibration curve for pyranine fluorescence as a function of pH was recorded. 200 mL of 
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buffer (5 mM MES, 5 mM Tricine, 5 mM NaCl, 5 mM KCl, 250 mM sucrose, pH 6.00; 
the same as used for the liposome interior when testing cation permeation) containing 2 
µM  pyranine  was  titrated  with  1  M  NaOH,  while  measuring  both  the  pyranine 
fluorescence intensity at 510 nm and the pH value after each successive addition. The 
measured curve was fitted with the empirical polynomial function:
y=ax+bx1 /2+cx1/3+dx1/4
The fitted function was  then used as a calibration curve to convert the measured time-
based fluorescence traces to changes in the intraliposomal proton concentration. 
Results
Effect of daptomycin on cation permeability
The permeability of liposomes for cations was measured using a coupled fluorescence 
assay that is based on the pH-sensitive indicator pyranine, whose fluorescence increases 
with  the  pH as  its  phenolic  OH group  dissociates  between  pH 6  and  8.5  [21].  The 
experimental rationale, with potassium as an example, is illustrated in Figure 2. Dilution 
of the pyranine-loaded liposomes into the final reaction buffer containing 100 mM KCl at 
pH 8 creates two opposite ion concentration gradients across the liposome membrane: the 
K+ concentration is higher outside, whereas the H+ concentration is higher inside (Figure 
2A). Addition of the proton ionophore CCCP alone to this system will cause little change 
to the pH within the liposomes, since the efflux of protons will very soon be restricted by 
the ensuing diffusion potential  (Figure 2B).  The internal pH will  change significantly 
only  after  addition  of  daptomycin,  if,  and  only  if,  daptomycin  allows  the  influx  of 
potassium ions.  Both  ion  gradients  will  then  dissipate,  the  interior  pH will  rise,  and 
pyranine will dissociate and fluoresce (Figure 2C). 
The findings obtained using this assay with different cations are illustrated in  Figure 3. 
Panel A shows that the experiment works as expected with valinomycin, a potassium-
specific ionophore. With potassium, but not with sodium, the combination of valinomycin 
and CCCP induces a rapid change that indicates swift dissipation of the proton gradient, 
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facilitated by exchange of protons and potassium ions across the membrane. CCCP alone 
does not induce an appreciable change in fluorescence, while valinomycin alone shows a 
minor one; it may be that valinomycin has a limited ability to translocate protons bound 
to it, as has been suggested earlier [22].  
Figure 3B shows the same experiment with daptomycin instead of valinomycin. Again, 
only the combination of daptomycin and CCCP induces a major change of fluorescence, 
while either agent alone induces negligible changes in fluorescence. This indicates that 
daptomycin allows the influx of potassium ions. Also note that the rate of fluorescence 
change  induced  with  daptomycin/CCCP  was  significantly  smaller  than  with 
valinomycin/CCCP, which indicates that under the given experimental conditions the rate 
of fluorescence change was constrained by daptomycin and not by CCCP. This latter 
conclusion is further supported by the experiments shown in Figures S2 and S3. 
Furthermore, when CCCP was added several minutes after daptomycin in order to allow 
lead time for daptomycin pore assembly before triggering ion gradient dissipation, the 
ensuing  fluorescence  traces  were  very  similar  to  those  obtained  with  simultaneous 
application (data not shown). This indicates that the rate of ion flux was not limited by 
the process of pore assembly, but rather by the permeability of the already assembled 
pores. 
When significantly higher concentrations of daptomycin were employed together with 
CCCP, the rate of permeabilization increased, but there was also a notable increase in the 
rate of fluorescence change in the absence of CCCP (data not shown). This agrees with a 
previous  study  showing  that,  at  higher  concentrations,  daptomycin  destabilizes  and 
induces  fusion  of  lipid  bilayers  [23].  We  therefore  used  a  concentration  of  1  μM 
throughout;  this  value  is  similar  to  minimal  inhibitory  concentrations  in  susceptible 
bacteria [24]. 
To further  investigate  the  ion  selectivity  and  functional  size  of  the  pores  formed  by 
daptomycin, the same experimental conditions were used on a series of cations (Figure 
3C).  The  various  metal  ions,  choline,  and  hexamethonium  (N,N,N,N',N',N'-
hexamethylhexane-1,6-diaminium) were all used as their respective chloride salts and at 
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the same molar concentrations. All metal ions produced a similar rate of fluorescence 
increase. Similar rates of permeabilization were also observed with lithium, rubidium, 
barium, and calcium (data not shown); however, calcium is also a cofactor of daptomycin 
activity,  which  might  conceivably  skew  this  measurement.  Compared  to  the  metal 
cations,  choline  and  hexamethonium  produced  significantly  lower  increases  in 
fluorescence intensity (Figure 3C). Both are organic cations and, in unhydrated form, are 
larger than the metal ions. 
Effect of daptomycin on the permeability of anions
To determine whether daptomycin pores also allow the permeation of anions, the assay 
format was varied slightly. Pyranine-loaded liposomes with high internal pH (8.00) were 
diluted  into a  reaction  buffer  containing 100 mM choline  chloride  at  low pH (6.00), 
creating H+ and Cl- gradients that point the same way. Choline has been shown above to 
be only slowly transported by daptomycin,  whereas proton transport by CCCP is fast 
(compare Figure 3A); therefore, an influx of chloride should mostly be compensated by a 
simultaneous influx of protons, lowering the interior pH and causing the fluorescence to 
drop. This, however, was not observed; the fluorescence intensity was not significantly 
affected  by  the  presence  of  daptomycin,  with  our  without  CCCP (Figure  4A).  We 
conclude that daptomycin pores have no or low permeability for chloride ions. 
Effect of daptomycin on the permeability of neutral solutes
DTNB (Ellman’s reagent) is useful for detection of thiol groups in compounds such as 
cysteine. Its disulfide bond is readily cleaved by thiols to produce 2-nitro-5-thiobenzoate 
(NTB-), which absorbs at 412 nm [25]. We here used it to test the permeation of thiols 
across daptomycin pores. In this experiment, DTNB-loaded liposomes were added to a 
solution containing 100 mM of thiol.
The  experiment  shown  in  Figure  4B  depicts  the  findings  obtained  with  cysteine. 
Absorption was measured every 2 minutes over a period of 10 minutes, which showed no 
significant change until 0.1% Triton X-100 was added. Addition of 1 µM daptomycin did 
not accelerate the reduction of DTNB (indeed it seemed to slightly delay it), indicating 
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that  the  daptomycin  pore  allows  no  or  only  slow  passage  of  cysteine  across  the 
membrane. 
Cysteine  has  a  neutral  net  charge,  but  it  is  not  uncharged.  Two  uncharged  thiols, 
dithiothreitol (DTT) and 2-mercaptoethanol, were also tested. These molecules, however, 
were found to swiftly enter the liposomes and reduce DTNB even at lower concentrations 
and in the absence of daptomycin, so that no conclusion could be reached as to their 
ability to be transported by daptomycin pores. 
These  findings  do  not  allow us  clearly assess  the  ability  of  daptomycin  to  transport 
neutral solutes; cysteine transport may be limited either by lack of a positive charge or by 
its molecular size.  
Estimation of the rate of ion flow across daptomycin pores
As illustrated in Figure 2, each proton that is to leave the liposome needs to be replaced 
by one (alkali metals and choline) or one half (magnesium and hexamethonium) cation 
that enters through a daptomycin pore. Therefore, a given decrease in the total (buffered 
and  unbuffered)  proton  concentration  corresponds  to  a  proportional  increase  in  the 
concentration of the test cation, and it is thus possible to estimate the rate of permeation 
through daptomycin pores from the rate of fluorescence change. 
The relationship between pyranine fluorescence intensity and total proton concentration 
was determined empirically by titrating pyranine-containing cation hydration buffer with 
NaOH.  The  titration  curve  was  mathematically  fitted  with  an  empirical  polynomial 
function  (Figure  5A),  which  was  then  used  to  convert  the  previously  acquired 
fluorescence traces to changes of intravesicular cation concentrations (Figure 5B). The 
rates are highest for the alkali metal ions and lowest for magnesium and hexamethonium. 
In Figure 5C, the rate of sodium transport during the first minute was approximated using 
a single-exponential fit. The parameters of this fit indicate an initial transport rate of 22 
μM per second. To estimate the number of ions actually transported, we need to consider 
that  the  experiment  observes  the  change  in  ion  concentration  only  within  the 
intraliposomal  volume.  Liposomes  with  100  nm  diameter  and  at  a  total  lipid 
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concentration  of  250  μM  should  enclose  approximately  0.08%  of  the  total  volume. 
Therefore, an apparent ion transport rate of 22 μM/s converts to a liposomal entry of only 
18 nM/s from the bulk volume. The daptomycin concentration is 1 μM; if all daptomycin 
molecules are indeed incorporated into functional pores, and  each pore is an oligomer 
that  consists  of  7  or  8  subunits  [14,  26],  the  average  transport  rate  of  each  pore  is 
approximately 0.12 sodium ions per second. While this is only a rough estimate, it  is 
clear that ion transport by daptomycin is many orders of magnitude slower than those of 
typical cellular ion channels or of gramicidin, which transports upward of 106 ions per 
seond under similar conditions [27] (compare also Figure S2).
Discussion 
In  previous  experiments,  we  have  shown  that  daptomycin  forms  oligomers  on  the 
membranes of liposomes consisting of PC and PG, as well as on bacterial cells [13, 15]. 
These oligomers were subequently shown to contain approximately 7 subunits each [14] 
and to be involved in the bactericidal action of daptomycin [16]. We recently proposed a 
revised and more detailed model, in which the oligomer comprises eight subunits, with 
four each in the inner and the outer membrane leaflet [26].Earlier studies had established 
that daptomycin depolarizes the cell membranes of susceptible bacteria [8-10]. From the 
closely parallel observations obtained with the liposome model and with bacterial cells 
regarding  oligomer  formation,  the  question  arose  whether  the  functional  daptomycin 
lesion could also be observed and characterized in the liposome model. 
The findings reported here show that this is indeed the case. Daptomycin was found to 
permeabilize  the  liposome  membranes  in  a  cation-selective  fashion.  The  rate  of 
permeation was virtually the same for all alkali metal ions. It was approximately twice 
lower  for  magnesium,  and  lower  again  for  the  organic  cations  choline  and 
hexamethonium, indicating that  the pore also discriminates between different  cations, 
most likely according to size.
When comparing the bare ions,  without  hydration shells,  the two organic cations are 
much  larger  than  all  of  the  metal  ions;  both  choline  and  hexamothonium  contain 
tetramethylammonium as  a  moiety,  which  has  an  unhydrated  diameter  of  5.7  Å. In 
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contrast, when we take the hydration shells into account, magnesium at 8.6  Å exceeds 
the alkali metals and the organic ions, which are all close to 7  Å (all ionic diameters 
according to [28]). In membrane nanofiltration experiments [29], sodium and potassium 
have been found to be more permeant than magnesium and calcium, and it was proposed 
that  nanopore  permeation  involved  the  partial  shedding  of  hydration  shells.  Partial 
dehydration may also be involved in ion permeation across the the daptomycin pore. The 
organic cations bind their hydration shells most weakly [30]; nevertheless, they are less 
readily transported than the alkali  metal ions, which suggests that daptomycin prefers 
ions  with  an  effective  radius  below  that  of  unhydrated  choline  or  hexamethonium. 
Chloride, in both hydrated and unhydrated form, is very similar in diameter to potassium; 
therefore, its  exclusion is apparently not caused by size but may be due to electrostatic 
repulsion between it and one of the several acidic residues on the daptomycin molecule. 
It seems likely that the pore is also permeable for protons; however, due to the very low 
free (as opposed to buffered) proton concentration at  near neutral pH, this would not 
result in a rapid dissipation of transmembrane proton gradients and therefore would not 
be detected in our assay.
The  observations  reported  here  agree  rather  well  with  previous  reports  on  the 
permeabilization of bacterial cells. Daptomycin depolarizes  Bacillus cells and disrupts 
their uptake of amino acids, which is mostly driven by cation cotransport, but does not 
induce leakage of already accumulated amino acids [9]. The major cations that control 
the membrane potential are potassium and sodium. In an intact cell, the permeability is 
higher  for  potassium  than  for  sodium,  which  creates  a  negative-inside  membrane 
potential.  Changing  the  permeability  balance  in  favor  of  sodium will  depolarize  the 
membrane. This would occur with either sodium-selective channels or with non-selective 
pores  such  as  those  formed  by  daptomycin,  which  indeed  reproducibly  induces 
depolarization. Interestingly,  one experimental study reported a short-lived yet distinct 
transient hyperpolarization, followed by depolarization [31]. The extracellular medium 
used in that study was low in sodium; in this situation, permeabilization for both sodium 
and potassium might produce a transient dominance of the strongly negative potassium 
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equilibrium potential,  which would then  collapse as  the cytosol  becomes  depleted of 
potassium through continued leakage. 
A quantitative  estimation  of  the  rate  of  ion  transport  for  a  single  daptomycin  pore 
indicated that  this  rate  is  several  orders  of  magnitude lower than that  of  gramicidin, 
another peptide antibiotic that permeabilizes membranes for cations. It must be noted that 
the transport rate obtained here for daptomycin is an average value; while it might indeed 
apply to each of the functional pores in the ensemble, it is also possible that only a small  
fraction of all daptomycin oligomers form functional pores, with correspondingly greater 
permeability, or that the pores alternate between closed and open states, with the latter 
only prevailing during a small fraction of the time. While the conductivity properties of 
the  individual  daptomycin  pore  must  be  determined  in  future  experiments,  the  low 
average  conductivity,  compared with  a  dedicated  channel  former  such as  gramicidin, 
might suggest that pore-formation may be only one of several aspects of daptomycin's 
bactericidal action. It should, however, be noted that no additional action mode has been 
biochemically  substantiated  [11].  Moreover,  liposome  permeabilization  is  readily 
observed with daptomycin concentrations equivalent to typical MIC values [10], even 
though the ratio of daptomycin molecules to membrane lipids is lower in a liposome expe 
than in a bacterial  culture freshly inoculated for MIC measurement;  this  supports the 
notion that membrane permeabilization is relevant to antibacterial activity. 
In sum, our study shows that a very simple artificial membrane model suffices to elicit  
and characterize  the  pore-forming activity  of  daptomycin.  The only lipid  specifically 
required for pore formation in our model is PG. A key role for PG in vivo is consistent 
with several studies on the causation of bacterial resistance to daptomycin [17-19]. The 
availability of a simple yet sufficient liposome  model for daptomycin pore formation 
should be useful in further characterizing the structure and action mode of daptomycin, as 
well as the molecular basis of bacterial resistance.
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Table 1
Buffers  and  indicators  used  to  detect  membrane  permeabilization  toward  different 
solutes.  The indicators  were dissolved in  the corresponding hydration buffer,  and the 
solution  was  then  used  to  rehydrate  PC/PG  lipid  films.  After  extrusion  of  the  lipid 
dispersion through polycarbonate membranes, unentrapped indicator was removed by gel 
filtration  using  the  corresponding  hydration  buffer.  In  experiments  with  anionic  or 
cationic test solutes, pH gradients were established by diluting the liposome samples into 
reaction buffers with different pH. Pyranine (8-hydroxypyrene-1,3,6-trisulfonic acid) and 
DTNB (5,5’-dithiobis-(2-nitrobenzoic acid)) were obtained from Sigma. 
Test solutes Hydration buffer Entrapped indicator pH value
Cations 5 mM MES, 5 mM Tricine,
5 mM NaCl, 5 mM KCl,
250 mM Sucrose
5 mM pyranine 6.00
Anions 5 mM MES, 5 mM Tricine,
5 mM NaCl, 5 mM KCl,
250 mM Sucrose
5 mM pyranine 8.00
Neutral solutes 
(thiols)
20 mM HEPES, 
150 mM NaCl,
250 mM Sucrose
5 mM DTNB 7.00
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Legends to Figures
Figure 1. Schematic of the structure of daptomycin. Arrows indicate amide bonds, except 
between kynurenine and threonine, where an ester bond between the carboxyl group of 
kynurenine and the side chain hydroxyl group of threonine closes the ring. 
Figure  2. Schematic  representation  of  the  pyranine-based  liposome  permeabilization 
assay, using K+ ions as an example. Liposomes loaded with pyranine were diluted into the 
final  reaction  buffer  to  create  two  opposite  ion  concentration  gradients  across  the 
membrane  (A).  Application  of  the  protonophor  CCCP alone  will  create  a  diffusion 
potential, which will prevent a major efflux of protons (B). If daptomycin is added also 
and allows K+ ions to enter, both ion gradients can dissipate, the pH in the liposome will 
rise, and pyranine fluorescence will increase (C). 
Figure 3. Time-based fluorescence traces of pyranine-loaded liposomes after exposure to 
different test solutes and permeabilizing agents, which were added at t=0. The interior pH 
was 6 and the exterior pH was 8. Test solutes added to the exterior buffer at 100 mM 
were KCl in B, and otherwise as indicated; “hexa” in C and D is hexamethonium. After 
300  seconds,  the  samples  were  solubilized  with  Triton-X100,  and  the  fluorescence 
monitored  for  another  minute.  The  fluorescence  intensity  observed  after  Triton 
solubilization was used to normalize each fluorescence trace.  A: Valinomycin (val., 0.5 
μM)  with  CCCP (5  nM)  permeabilize  liposomes  for  potassium  but  not  sodium.  B: 
Daptomycin (1 μM) plus CCCP (5 nM) also causes permeabilization for potassium.  C: 
Permeabilization traces  obtained  with  both  daptomycin  and  CCCP  present,  after 
subtraction of the traces obtained with CCCP only. D: Averages and standard deviations 
of  fluorescence  intensities  after  300  seconds  of  incubation,  for  3  or  4  independent 
experiments performed as in C (“chol.” is choline).
Figure 4. Absence of liposome permeabilization toward chloride (A) and cysteine (B). A: 
Pyranine-loaded  liposomes  with  an  interior  pH  of  6  were  diluted  100  mM  choline 
chloride,  pH  8,  and  CCCP  (5  nM)  and  daptomycin  (1 μM)  were  added  at  t=0. 
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Permeabilization for chloride should have resulted in an accelerated dissipation of the pH 
gradient and concomitant drop in pyranine fluorescence. The experiment shown is one of 
4  independent  ones  and  is  representative.  B: Time  course  of  reduction  of  DTNB 
entrapped in liposomes by 100 mM cysteine added to the outside, in the absence and 
presence  of  daptomycin  (1  μM).  Reduction  of  DTNB  results  in  an  increase  of  the 
absorption at 412 nm. After the last reading at 10 minutes, samples were solubilized with 
Triton-X100, resulting in immediate complete DTNB reduction. Error bars are standard 
deviations  from three  independent  experiments.  Daptomycin  does  not  increase  in  the 
permeation of cysteine into the liposomes. 
Figure 5. Conversion of observed pyranine fluorescence changes to cation flow rates. A 
calibration  curve  relating  total  (buffered  and  unbuffered)  proton  concentration  to 
pyranine  fluorescence  intensity  was  obtained  by  titrating  a  solution  matching  the 
liposome interior with NaOH (A). A polynomical function was fitted to the measured 
values.  In  panel  B,  the  polynomial  function  obtained  in  A was  applied  to  the  raw 
fluorescence traces shown in Figure 3C in order to transform them to ion fluxes. The flow 
rates for hexamethonium and Mg++ were then divided by 2, as each of these cations is 
exchanged for 2 protons. In C, an exponential function was fitted to the transport curve 
for sodium in order to estimate the initial transport rate (see text for further details). 
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